NO891046L - Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.

Info

Publication number
NO891046L
NO891046L NO89891046A NO891046A NO891046L NO 891046 L NO891046 L NO 891046L NO 89891046 A NO89891046 A NO 89891046A NO 891046 A NO891046 A NO 891046A NO 891046 L NO891046 L NO 891046L
Authority
NO
Norway
Prior art keywords
alkyl
stands
formula
compounds
het
Prior art date
Application number
NO89891046A
Other languages
English (en)
Norwegian (no)
Other versions
NO891046D0 (no
Inventor
Kurt Schromm
Gerhard Walther
Hubert Heuer
Gojko Muacevic
Franz Birke
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO891046D0 publication Critical patent/NO891046D0/no
Publication of NO891046L publication Critical patent/NO891046L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO89891046A 1988-03-12 1989-03-10 Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. NO891046L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3808283A DE3808283A1 (de) 1988-03-12 1988-03-12 Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO891046D0 NO891046D0 (no) 1989-03-10
NO891046L true NO891046L (no) 1989-09-13

Family

ID=6349565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891046A NO891046L (no) 1988-03-12 1989-03-10 Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.

Country Status (14)

Country Link
EP (1) EP0335144A1 (fi)
JP (1) JPH01275571A (fi)
KR (1) KR890014525A (fi)
AU (1) AU3119089A (fi)
DD (1) DD283619A5 (fi)
DE (1) DE3808283A1 (fi)
DK (1) DK117089A (fi)
FI (1) FI891153A (fi)
HU (1) HUT51615A (fi)
IL (1) IL89571A0 (fi)
NO (1) NO891046L (fi)
PT (1) PT89977A (fi)
YU (1) YU50689A (fi)
ZA (1) ZA891799B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002731A1 (de) * 1989-08-19 1991-03-07 Boehringer Ingelheim Kg Substituierte n-heterocyclen, ihre herstellung und verwendung
AU2000223275A1 (en) * 2000-02-08 2001-08-20 Yamanouchi Pharmaceutical Co..Ltd. Novel triazole derivatives
JP3873746B2 (ja) * 2000-05-19 2007-01-24 アステラス製薬株式会社 トリアゾール誘導体
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
US11555031B2 (en) 2017-03-20 2023-01-17 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
CN110467579B (zh) * 2019-07-30 2020-08-25 浙江理工大学 一种5-三氟甲基取代的1,2,4-三氮唑化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1378617A (en) * 1972-05-05 1974-12-27 Upjohn Co Triazolylbenzophenones
FR2269938A2 (en) * 1974-05-08 1975-12-05 Delalande Sa 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2539127B1 (fr) * 1983-01-10 1985-08-23 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicaments
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines

Also Published As

Publication number Publication date
ZA891799B (en) 1990-11-28
PT89977A (pt) 1989-11-10
KR890014525A (ko) 1989-10-24
AU3119089A (en) 1989-09-14
YU50689A (en) 1991-04-30
FI891153A0 (fi) 1989-03-10
DK117089D0 (da) 1989-03-10
IL89571A0 (en) 1989-09-10
FI891153A (fi) 1989-09-13
DK117089A (da) 1989-09-13
HUT51615A (en) 1990-05-28
EP0335144A1 (de) 1989-10-04
NO891046D0 (no) 1989-03-10
DD283619A5 (de) 1990-10-17
JPH01275571A (ja) 1989-11-06
DE3808283A1 (de) 1989-09-21

Similar Documents

Publication Publication Date Title
US5314883A (en) 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones
US7947707B2 (en) Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
FI73670B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenoxialkyl-1,2,4-triazol-3-on derivat.
AU2003230829B2 (en) Triazole derivatives as tachykinin receptor antagonists
JP3290657B2 (ja) アンギオテンシンii拮抗剤として活性な酸性アラルキルトリアゾール誘導体
US4618617A (en) Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof
JP4497815B2 (ja) 新規な複素環式アミド誘導体およびドーパミンd3受容体リガンドとしてのその使用
BRPI0212775B1 (pt) composto de 1,2,4-triazol e medicamento
CA2610310A1 (en) Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
JP2005533858A (ja) 化合物
JPH03255063A (ja) セロトニン拮抗剤、それらの製造およびそれらを含有する薬学的組成物
KR20090031605A (ko) 신규한 피리딘 유사체
JPH04257570A (ja) ピペラジン誘導体
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
JP2005501826A (ja) 置換イソインドールおよびそれらの使用
NO179975B (no) Analogifremgangsmåte for fremstilling av heterocykliske derivater
NO873650L (no) Dihydropyridinderivater.
JPH039114B2 (fi)
NO891046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
CA2072775A1 (en) Substituted triazolinones
IE75733B1 (en) Benzene pyridine and pyrimidine derivative
HU195211B (en) Process for producing 5-alkyl-1-phenyl-2-(piperazinoalkyl)-pyrazolin-3-one derivatives and pharmaceutical preparations comprising the same
JPH11240832A (ja) アミド若しくはアミン誘導体
Takada et al. Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors
JP3012338B2 (ja) アリールおよびヘテロアリールアルコキシナフタレン誘導体